OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Joaquín Martínez‐López, Javier de la Cruz, Rodrigo Gil-Manso, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1497-1497
Open Access | Times Cited: 11
Joaquín Martínez‐López, Javier de la Cruz, Rodrigo Gil-Manso, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1497-1497
Open Access | Times Cited: 11
Showing 11 citing articles:
Recommendations on prevention of infections during chimeric antigen receptor T ‐cell and bispecific antibody therapy in multiple myeloma
Meera Mohan, Rajshekhar Chakraborty, Susan Bal, et al.
British Journal of Haematology (2023) Vol. 203, Iss. 5, pp. 736-746
Open Access | Times Cited: 39
Meera Mohan, Rajshekhar Chakraborty, Susan Bal, et al.
British Journal of Haematology (2023) Vol. 203, Iss. 5, pp. 736-746
Open Access | Times Cited: 39
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody
Shuhei Maruyama, Daiki Wada, Shuji Kanayama, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Shuhei Maruyama, Daiki Wada, Shuji Kanayama, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer
Seyed M. Hosseini‐Moghaddam, Frances A. Shepherd, Sarah Swayze, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2331617-e2331617
Open Access | Times Cited: 10
Seyed M. Hosseini‐Moghaddam, Frances A. Shepherd, Sarah Swayze, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2331617-e2331617
Open Access | Times Cited: 10
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
Joaquín Martínez‐López, Javier de la Cruz, Rodrigo Gil-Manso, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 379-379
Open Access | Times Cited: 2
Joaquín Martínez‐López, Javier de la Cruz, Rodrigo Gil-Manso, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 379-379
Open Access | Times Cited: 2
Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights
Heng Joo Ng, Maaz Kamal Alata, Quang The Nguyen, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Heng Joo Ng, Maaz Kamal Alata, Quang The Nguyen, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, et al.
Blood Reviews (2024) Vol. 66, pp. 101218-101218
Open Access | Times Cited: 1
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, et al.
Blood Reviews (2024) Vol. 66, pp. 101218-101218
Open Access | Times Cited: 1
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mohammed Nooruzzaman, Katherine Johnson, Ruchi Rani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Outcomes and Patterns of Evolution of Patients with Hematological Malignancies during the COVID-19 Pandemic: A Nationwide Study (2020–2022)
Rafael García Carretero, María Ordoñez-Garcia, Ruth Gil-Prieto, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5400-5400
Open Access
Rafael García Carretero, María Ordoñez-Garcia, Ruth Gil-Prieto, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5400-5400
Open Access
COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study
Zilu Zhang, Jingtao Huang, Luxiang Wang, et al.
Blood Science (2024) Vol. 6, Iss. 2, pp. e00183-e00183
Open Access
Zilu Zhang, Jingtao Huang, Luxiang Wang, et al.
Blood Science (2024) Vol. 6, Iss. 2, pp. e00183-e00183
Open Access
SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment
Patricia García Ramírez, Marta Callejas Charavía, Raquel Oliva Martin, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 961-961
Open Access
Patricia García Ramírez, Marta Callejas Charavía, Raquel Oliva Martin, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 961-961
Open Access
